Impact of the COVID-19 pandemic on cervical cancer screening participation, abnormal cytology prevalence and screening interval in Catalonia DOI Creative Commons
Claudia Robles,

Laura Monfil,

Raquel Ibáñez

et al.

Frontiers in Oncology, Journal Year: 2024, Volume and Issue: 14

Published: May 29, 2024

Background The COVID-19 pandemic led to a national lockdown and the interruption of all cancer preventive services, including cervical screening. We aimed assess impact on opportunistic screening participation, abnormal cytology (ASCUS+) prevalence interval in 2020 2021 within Public Health System Catalonia, Spain. Methods Individual data HPV testing women aged 25–65 from 2014 were retrieved Information for Primary Care Services (SISAP). Time-series regression models used estimate expected participation 2021. was determined by comparing observed values (ratios). Additionally, changes trends between assessed fitting Piecewise linear model. Results Cervical decreased 38.8% 2.2% 2021, respectively, with most significant (-96.1%) occurring April 2020. Among older women, lower, it took longer recover. Abnormal 1.4 times higher than variations age (range=1.1–1.5). From June onwards, trend significantly changed an increase 0.59 3.57 months per year, resulting median time 48 December Conclusions During pandemic, fewer have participated screening, has increased, is more prolonged before. potential lifetime risk implications highlight need organized HPV-based

Language: Английский

Impact of the COVID-19 pandemic on cervical cancer screening participation, abnormal cytology prevalence and screening interval in Catalonia DOI Creative Commons
Claudia Robles,

Laura Monfil,

Raquel Ibáñez

et al.

Frontiers in Oncology, Journal Year: 2024, Volume and Issue: 14

Published: May 29, 2024

Background The COVID-19 pandemic led to a national lockdown and the interruption of all cancer preventive services, including cervical screening. We aimed assess impact on opportunistic screening participation, abnormal cytology (ASCUS+) prevalence interval in 2020 2021 within Public Health System Catalonia, Spain. Methods Individual data HPV testing women aged 25–65 from 2014 were retrieved Information for Primary Care Services (SISAP). Time-series regression models used estimate expected participation 2021. was determined by comparing observed values (ratios). Additionally, changes trends between assessed fitting Piecewise linear model. Results Cervical decreased 38.8% 2.2% 2021, respectively, with most significant (-96.1%) occurring April 2020. Among older women, lower, it took longer recover. Abnormal 1.4 times higher than variations age (range=1.1–1.5). From June onwards, trend significantly changed an increase 0.59 3.57 months per year, resulting median time 48 December Conclusions During pandemic, fewer have participated screening, has increased, is more prolonged before. potential lifetime risk implications highlight need organized HPV-based

Language: Английский

Citations

1